Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?

PURPOSE: Despite evidence supporting at least five years of endocrine therapy for early breast cancer, many women discontinue therapy early. We investigated the impact of initial therapy type and specific comorbidities on discontinuation of endocrine therapy in clinical practice. METHODS: We identif...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kemp, Anna, Preen, David B, Saunders, Christobel, Boyle, Frances, Bulsara, Max, Malacova, Eva, Roughead, Elizabeth E
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058005/
https://ncbi.nlm.nih.gov/pubmed/24936397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-282
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados